IDEAYA Biosciences, Inc.
IDYA • NASDAQ
IDEAYA Biosciences, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Yujiro S. Hata, with a market cap of $2.8B.
CEOYujiro S. Hata
Market Cap$2.8B
Biotechnology
Healthcare
Employees124.0
Websiteideayabio.com
Country
United States of America
Next Earnings
Upcoming earnings announcement for IDEAYA Biosciences, Inc.
Date
Tuesday, May 5, 2026 (in 3 months)
Timing
Before Market Open (6:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$1.02
Revenue Estimate
$5.2M
Earnings History
Past 11 earnings reports for IDEAYA Biosciences, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 4, 2025 | Q3 2025 | $1.33Est: -$0.55 | +341.8% | $207.8MEst: $87.7M | +137.1% |  10-Q |
| Aug 5, 2025 | Q2 2025 | -$0.88Est: -$0.82 | -7.3% | -Est: $4.5M | -100.0% | 10-Q |
| May 6, 2025 | Q1 2025 | -$0.82Est: -$0.69 | -18.8% | -Est: $2.3M | -100.0% | 10-Q |
| Feb 13, 2025 | Q4 2024 | -$1.49Est: -$0.61 | -144.3% | $7.0MEst: $4.5M | +54.2% | 10-K |
| Nov 4, 2024 | Q3 2024 | -$0.60Est: -$0.67 | +10.4% | -Est: $3.8M | -100.0% | 10-Q |
| Aug 6, 2024 | Q2 2024 | -$0.68Est: -$0.54 | -25.9% | -Est: $4.3M | -100.0% | 10-Q |
| May 7, 2024 | Q1 2024 | -$0.53Est: -$0.51 | -3.9% | -Est: $4.5M | -100.0% | 10-Q |
| Feb 20, 2024 | Q4 2023 | -$0.52Est: -$0.47 | -10.6% | $3.9MEst: $8.8M | -55.6% | 10-K |
| Nov 7, 2023 | Q3 2023 | -$0.46Est: -$0.49 | +6.1% | $8.0MEst: $7.3M | +9.8% | — |
| Aug 10, 2023 | Q2 2023 | -$0.50Est: -$0.56 | +10.7% | $3.5MEst: $4.5M | -21.4% | 10-Q |
| May 9, 2023 | Q1 2023 | -$0.49Est: -$0.55 | +10.9% | $7.9MEst: $6.4M | +22.9% | — |